In M&A news: Xellia Pharmaceuticals announced that Novo, the holding company of the Novo Group, has puchased all shares of the group for approximately $700 million from 3i and other current shareholders. Read the full story

 Stryker Corp.President and CEO Kevin Lobo said the Kalamazoo-based medical device company is looking for a merger and acquisition deal. Read the full story